Press Releases
Sun Pharma Announces FDA Approval of Next Generation BLU-U Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associates referred…
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
Pathos AI, (www.pathos.com), a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million…
Tempus Enters Multi-Year Strategic Collaboration with Boehringer Ingelheim to Advance its Cancer Pipeline
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care,…
Recipharm and PLG announce strategic partnership to accelerate development projects
Recipharm, a leading global contract development and manufacturing organisation (CDMO), and ProductLife Group (PLG), a global provider product development and…
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1…
PTC Therapeutics Receives Positive CHMP Opinion for Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European…
Guardant Health announces strategic collaboration with Pfizer
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a strategic collaboration with Pfizer, Inc. (NYSE: PFE),…
Latest update on U.S. FDA BLA for Novavax’s COVID-19 Vaccine
We believe that our Biologics License Application (BLA) is approvable based on conversations with the U.S. Food and Drug Administration…
FDA grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-cell therapy for incurable pediatric brain tumors
BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS),…
Viatris Files Supplemental New Drug Applications to Japan’s Ministry of Health, Labor and Welfare for the Approval of EFFEXOR for the Treatment of Generalized Anxiety Disorder
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has filed applications to the Ministry of Health, Labor and…